Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives.

about

Moving forward with metronomic chemotherapy: meeting report of the 2nd International Workshop on Metronomic and Anti-Angiogenic Chemotherapy in Paediatric Oncology.New anti-angiogenic strategies in pediatric solid malignancies: agents and biomarkers of a near future.

P2860

Q35116804-BA8B0F8C-24AE-4AAB-89C7-323E7EC92DFB Q37752435-59CC70DE-2AB4-4863-93FC-9447265AA2EF

P2860

Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives.

Item

http://www.wikidata.org/entity/Q37528441

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antiangiogenic (metronomic) ch ...... rrent and future perspectives.

@en

Antiangiogenic

@nl

type

Item

label

Antiangiogenic (metronomic) ch ...... rrent and future perspectives.

@en

Antiangiogenic

@nl

prefLabel

Antiangiogenic (metronomic) ch ...... rrent and future perspectives.

@en

Antiangiogenic

@nl

P1476

Antiangiogenic (metronomic) ch ...... urrent and future perspectives

@en

P2093

David P Samuel

http://www.w3.org/2001/XMLSchema#string

Patrick Y Wen

http://www.w3.org/2001/XMLSchema#string

P2860

Genes expressed in human tumor endothelium

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

Thalidomide is an inhibitor of angiogenesis

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancer

Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults

Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.

Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer

Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide.

Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors.

P304

973-983

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543780903025752

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mark W. Kieran

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19548852

http://www.w3.org/2001/XMLSchema#string

Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives.

about

P2860

P2860

Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698